SCHEMBL4378529

SCHEMBL4378529

CC(=O)c1ccccc1OCC(=O)N1CCN(c2ccncc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.62
HTT P42858 3/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
CYP2C9 P11712 3/20 0.60
CYP2C19 P33261 2/20 0.60
CYP3A4 P08684 2/20 0.60
KMT2A Q03164 1/20 0.60
CYP1A2 P05177 1/20 0.60
MAPT P10636 3/20 0.55
KDM4E B2RXH2 3/20 0.55
LMNA P02545 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TP53 P04637 1/20 0.54
L3MBTL1 Q9Y468 3/20 0.52
PARP1 P09874 1/20 0.52
TSHR P16473 2/20 0.51
MAPK1 P28482 1/20 0.50
CYP2D6 P10635 1/20 0.50
GLA P06280 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4382890 0.99 ALDH1A1 (0.61) ALDH1A1HTTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL4375414 0.86 TSHR (0.70) ALDH1A1HTTCYP2C9CYP2C19CYP3A4
SCHEMBL4379305 0.84 KMT2A (0.65) ALDH1A1HTTSMN1; SMN2CYP2C9CYP3A4
SCHEMBL4378341 0.83 HTT (0.76) ALDH1A1HTTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL4379063 0.81 KDM4E (0.82) ALDH1A1HTTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL14218134 0.79 ALDH1A1 (0.57) ALDH1A1HTTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL4382063 0.79 HTT (0.63) ALDH1A1HTTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL4384247 0.79 HRH3 (0.66) ALDH1A1HTTSMN1; SMN2CYP2C9CYP3A4
SCHEMBL4378935 0.76 NPC1 (0.51) ALDH1A1HTTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL4377632 0.76 MAPK1 (0.75) ALDH1A1HTTSMN1; SMN2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP claimed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 ALDH1A1 1907/4885HTT 360/4885SMN1; SMN2 2684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.